Eidelman Virant Capital’s Corcept Therapeutics CORT Stock Holding History

Eidelman Virant Capital’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$140K	–	105
2018 Q3	$140K	Hold	10,000	–	–	0.07%	106
2018 Q2	$157K	Sell	10,000 -30,000	-75%	-$522K	0.1%	94
2018 Q1	$658K	Hold	40,000	–	–	0.43%	61
2017 Q4	$722K	Hold	40,000	–	–	0.42%	65
2017 Q3	$722K	Sell	40,000 -12,000	-23%	-$179K	0.43%	65
2017 Q2	$613K	Buy	+52,000	New	+$565K	0.35%	72

Other funds holding CORT

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return